IC
PRAX icon

IEQ Capital’s Praxis Precision Medicines PRAX Stock Holding History

IEQ Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Sell
815
-27
-3% -$8.55K ﹤0.01% 1687
2026
Q1 		$271K Buy
842
+27
+3% +$8.35K ﹤0.01% 1560
2025
Q4 		$240K Buy
+815
New +$152K ﹤0.01% 1626

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

IEQ Capital's PRAX Position: Q2 2026 in Review

IEQ Capital reduced its Praxis Precision Medicines (PRAX) stake by 3.2% in Q2 2026, selling an estimated $8.55K and leaving 815 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

IEQ Capital first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • IEQ Capital held 815 shares of Praxis Precision Medicines worth $273K as of Q2 2026.
  • IEQ Capital sold 27 Praxis Precision Medicines shares in Q2 2026, an estimated $8.55K.
  • Praxis Precision Medicines made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1687 holding.
  • IEQ Capital first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.